Skip Navigation
Search
Drug Development, from Chemistry to Diagnostics and Therapies
Development of novel diagnostics and therapeutics requires expertise and technologies ranging from computational simulations, structural biology, pharmacology, medicinal chemistry and imagining, to clinical studies and academia-industry relations.
| Team Members |
| Markus Seeliger, Pharmacology (Lead) |
| Maurizio del Poeta, Microbiology & Immunology |
| Michael Airola, Biochemistry |
| John Haley, Pathology |
| Eszter Boros, Chemistry |
| Mark Slifstein, Psychiatry |
| Diane Fabel, Center for Biotechnology |
| OPD Rep: Karrie Gash |